Related references
Note: Only part of the references are listed.Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication
Johanna Theruvath et al.
NATURE MEDICINE (2022)
Molecular Basis and Role of Siglec-7 Ligand Expression on Chronic Lymphocytic Leukemia B Cells
Lan-Yi Chang et al.
FRONTIERS IN IMMUNOLOGY (2022)
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
Benjamin A. H. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
Simon Wisnovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells
Atsushi Yoshimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer
Daniel S. C. Butler et al.
NATURE BIOTECHNOLOGY (2021)
Probing the binding specificities of human Siglecs by cell-based glycan arrays
Christian Bull et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The MYC oncogene - the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity
Itziar Ibarlucea-Benitez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC
Lydia Boike et al.
CELL CHEMICAL BIOLOGY (2021)
Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases
Sayaka Akiyoshi et al.
MOLECULAR INFORMATICS (2020)
Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Target gene-independent functions of MYC oncoproteins
Apoorva Baluapuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
Stephanie van de Wall et al.
TRENDS IN IMMUNOLOGY (2020)
Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes
Kevin K. Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Discovery of a new sialic acid binding region that regulates Siglec-7
Nao Yamakawa et al.
SCIENTIFIC REPORTS (2020)
Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia
Andreas Kloetgen et al.
NATURE GENETICS (2020)
Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma
Hsuan-Hsuan Lu et al.
EBIOMEDICINE (2020)
MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies
Srividya Swaminathan et al.
NATURE COMMUNICATIONS (2020)
Targeted glycan degradation potentiates the anticancer immune response in vivo
Melissa A. Gray et al.
NATURE CHEMICAL BIOLOGY (2020)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing
Satoshi Uchiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
Leonhard Mockl et al.
DEVELOPMENTAL CELL (2019)
The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface
Noboru Hashimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
Quentin Haas et al.
CANCER IMMUNOLOGY RESEARCH (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
Brittany L. Allen-Petersen et al.
BIODRUGS (2019)
The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth
Arvin M. Gouw et al.
CELL METABOLISM (2019)
The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity
Anne Barenwaldt et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Heinz Laubli et al.
FRONTIERS IN IMMUNOLOGY (2019)
Translation control of the immune checkpoint in cancer and its therapeutic targeting
Yichen Xu et al.
NATURE MEDICINE (2019)
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability
Kenichi Iwai et al.
EMBO MOLECULAR MEDICINE (2018)
Distinct human (1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells
Nandini Mondal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Expression of Siglec-E Alters the Proteome of Lipopolysaccharide (LPS)-Activated Macrophages but Does Not Affect LPS-Driven Cytokine Production or Toll-Like Receptor 4 Endocytosis
Manjula Nagala et al.
FRONTIERS IN IMMUNOLOGY (2018)
Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy
Olivier Benac et al.
CANCER RESEARCH (2018)
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Michal A. Stanczak et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Targeting oncogenic Myc as a strategy for cancer treatment
Hui Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E
Shoib Siddiqui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
V. Atsaves et al.
LEUKEMIA (2017)
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
Lynh Nguyen et al.
GENES (2017)
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Roderik M. Kortlever et al.
CELL (2017)
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Michael J. Topper et al.
CELL (2017)
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
Richard Beatson et al.
NATURE IMMUNOLOGY (2016)
Precision glycocalyx editing as a strategy for cancer immunotherapy
Han Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Cheryl M. Koh et al.
NATURE (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation
Shaun Spence et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Aberrant Glycosylation Promotes Lung Cancer Metastasis through Adhesion to Galectins in the Metastatic Niche
Nathan E. Reticker-Flynn et al.
CANCER DISCOVERY (2015)
ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia
Sofie Peirs et al.
BLOOD (2014)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma
Ming Shi et al.
EUROPEAN JOURNAL OF CANCER (2014)
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance
Camilla Jandus et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Arianna Sabo et al.
NATURE (2014)
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
Susanne Walz et al.
NATURE (2014)
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
Jason E. Hudak et al.
NATURE CHEMICAL BIOLOGY (2014)
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Livia S. Eberlin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
Heinz Laubli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Negative Regulation of Notch Signaling by Xylose
Tom V. Lee et al.
PLOS GENETICS (2013)
Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting
Cory D. Rillahan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Zuqin Nie et al.
CELL (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition
Keiichiro Sakuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors
Heather G. LaBreche et al.
BMC MEDICAL GENOMICS (2011)
Letter to the Glyco-Forum: Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities
Christoph Geisler et al.
GLYCOBIOLOGY (2011)
Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation
Hongkai Ji et al.
PLOS ONE (2011)
The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance
Jan van Riggelen et al.
GENES & DEVELOPMENT (2010)
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma et al.
NATURE CELL BIOLOGY (2010)
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Kerry J. Savage et al.
BLOOD (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
High-efficiency labeling of sialylated glycoproteins on living cells
Ying Zeng et al.
NATURE METHODS (2009)
Crosstalk Between c-Myc and Ribosome in Ribosomal Biogenesis and Cancer
Mu-Shui Dai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
Maria Barna et al.
NATURE (2008)
Novel c-MYC target genes mediate differential effects on cell proliferation and migration
David Cappellen et al.
EMBO REPORTS (2007)
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
Teresa Palomero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc
Vishva Mitra Sharma et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
Glycans in cancer and inflammation. Potential for therapeutics and diagnostics
DH Dube et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development
SS Grewal et al.
NATURE CELL BIOLOGY (2005)
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
C Grandori et al.
NATURE CELL BIOLOGY (2005)
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
A Arabi et al.
NATURE CELL BIOLOGY (2005)
The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils
JQQ Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Construction of a human glycogene library and comprehensive functional analysis
H Narimatsu
GLYCOCONJUGATE JOURNAL (2004)
Low molecular weight inhibitors of Myc-Max interaction and function
XY Yin et al.
ONCOGENE (2003)
A role for c-Myc in the regulation of ribosomal RNA processing
I Schlosser et al.
NUCLEIC ACIDS RESEARCH (2003)
c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression
TA Baudino et al.
GENES & DEVELOPMENT (2002)
The human sialyltransferase family
A Harduin-Lepers et al.
BIOCHIMIE (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Share Paper
